Ac-SDKP ameliorates the progression of lupus nephritis in MRL/lpr mice

International Immunopharmacology

Volumn 14, Issue 4, 2012, Pages 401-409

  Tan, Hechang ^a   Zhao, Jijun ^a   Wang, Shuang ^a   Zhang, Lili ^a   Wang, Hongyue ^a   Huang, Bin ^a   Liang, Yingjie ^a   Yu, Xueqing ^a   Yang, Niansheng ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Ac SDKP; Fibrosis; Inflammation; Lupus nephritis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; DOUBLE STRANDED DNA; DOUBLE STRANDED DNA ANTIBODY; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SERASPENIDE; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DRUG BLOOD LEVEL; FEMALE; FIBROBLAST; HISTOPATHOLOGY; IMMUNE COMPLEX DEPOSITION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEINURIA; T LYMPHOCYTE;

ACTINS; ANIMALS; ANTIBODIES, ANTINUCLEAR; BODY WEIGHT; CHEMOKINE CCL2; DRUG ADMINISTRATION SCHEDULE; FEMALE; FIBRONECTINS; GENE EXPRESSION REGULATION; INFLAMMATION; KIDNEY; LEUKOCYTES; LUPUS NEPHRITIS; MICE; MICE, INBRED MRL LPR; NF-KAPPA B; OLIGOPEPTIDES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84867011283     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.07.023     Document Type: Article

References (33)

1. J.S. Cameron Lupus nephritis J Am Soc Nephrol 10 1999 413 424
2. M.H. Foster T cells and B cells in lupus nephritis Semin Nephrol 27 2007 47 58
3. A. Gigante, M.L. Gasperini, A. Afeltra, B. Barbano, D. Margiotta, and R. Cianci Cytokines expression in SLE nephritis Eur Rev Med Pharmacol Sci 15 2011 15 24
4. O. Kulkarni, and H.J. Anders Chemokines in lupus nephritis Front Biosci 13 2008 3312 3320
5. K. Yamamoto, and D.J. Loskutoff Expression of transforming growth factor-beta and tumor necrosis factor-alpha in the plasma and tissues of mice with lupus nephritis Lab Invest 80 2000 1561 1570
6. T. Yamamoto, N.A. Noble, A.H. Cohen, C.C. Nast, A. Hishida, and L.I. Gold Expression of transforming growth factor-beta isoforms in human glomerular diseases Kidney Int 49 1996 461 469
7. R.W. Chan, F.M. Lai, E.K. Li, L.S. Tam, T.Y. Wong, and C.Y. Szeto Expression of chemokine and fibrosing factor messenger rna in the urinary sediment of patients with lupus nephritis Arthritis Rheum 50 2004 2882 2890
8. P. Pradelles, Y. Frobert, C. Creminon, E. Liozon, A. Massé, and E. Frindel Negative regulator of pluripotent hematopoietic stem cell proliferation in human white blood cells and plasma as analysed by enzyme immunoassay Biochem Biophys Res Commun 170 1990 986 993
9. M.A. Cavasin, N.E. Rhaleb, X.P. Yang, and O.A. Carretero Prolyl oligopeptidase is involved in release of the antifibrotic peptide ac-sdkp Hypertension 43 2004 1140 1145
10. U. Sharma, N.E. Rhaleb, S. Pokharel, P. Harding, S. Rasoul, and H. Peng Novel anti-inflammatory mechanisms of n-acetyl-ser-asp-lys-pro in hypertension-induced target organ damage Am J Physiol Heart Circ Physiol 294 2008 H1226 H1232
11. N. Iwamoto, H.J. Xano, T. Yoshioka, H. Shiraga, K. Nitta, and T. Muraki Acetyl-seryl-aspartyl-lysyl-proline is a novel natural cell cycle regulator of renal cells Life Sci 66 2000 PL221 PL226
12. K. Kanasaki, D. Koya, T. Sugimoto, M. Isono, A. Kashiwagi, and M. Haneda N-acetyl-seryl-aspartyl-lysyl-proline inhibits tgf-beta-mediated plasminogen activator inhibitor-1 expression via inhibition of smad pathway in human mesangial cells J Am Soc Nephrol 14 2003 863 872
13. L. Zhang, N. Yang, S. Wang, B. Huang, F. Li, and H. Tan Adenosine 2A receptor is protective against renal injury in MRL/lpr mice Lupus 20 2011 667 677
14. H. Peters, W.A. Border, M. Rückert, S. Krämer, H.H. Neumayer, and N.A. Noble L-arginine supplementation accelerates renal fibrosis and shortens life span in experimental lupus nephritis Kidney Int 63 2003 1382 1392
15. G. Pérez de Lema, F.J. Lucio-Cazaña, A. Molina, B. Luckow, H. Schmid, and C. de Wit Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease Kidney Int 66 2004 1018 1028
16. F. Yang, X.P. Yang, Y.H. Liu, J. Xu, O. Cingolani, and N.E. Rhaleb Ac-SDKP reverses inflammation and fibrosis in rats with heart failure after myocardialinfarction Hypertension 43 2004 229 236
17. Y. Sun, F. Yang, J. Yan, Q. Li, Z. Wei, and H. Feng New anti-fibrotic mechanisms of n-acetyl-seryl-aspartyl -lysyl-proline in silicon dioxide-induced silicosis Life Sci 87 2010 232 239
18. Y.W. Chen, B.W. Liu, Y.J. Zhang, Y.W. Chen, G.F. Dong, and X.D. Ding Preservation of basal AcSDKP attenuates carbon tetrachloride-induced fibrosis in the rat liver J Hepatol 53 2010 528 536
19. M. Omata, H. Taniguchi, D. Koya, K. Kanasaki, R. Sho, and Y. Kato N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis J Am Soc Nephrol 17 2006 674 685
20. T.D. Liao, X.P. Yang, M. D'Ambrosio, Y. Zhang, N.E. Rhaleb, and O.A. Carretero N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal injury and dysfunction in hypertensive rats with reduced renal mass: council for high blood pressure research Hypertension 55 2010 459 467
21. H. Bagavant, and S.M. Fu Pathogenesis of kidney disease in systemic lupus erythematosus Curr Opin Rheumatol 21 2009 489 494
22. S. Hemmerich, C. Paavola, A. Bloom, S. Bhakta, R. Freedman, and D. Grunberger Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2 Biochemistry 38 1999 13013 13025
23. O. Kulkarni, R.D. Pawar, W. Purschke, D. Eulberg, N. Selve, and K. Buchner Spiegelmer inhibition of CCL2/MCP-1 ameliorates lupus nephritis in MRL-(Fas)lpr mice J Am Soc Nephrol 18 2007 2350 2358
24. M. Papaspyridonos, E. McNeill, J.P. de Bono, A. Smith, K.G. Burnand, and K.M. Channon Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction Arterioscler Thromb Vasc Biol 28 2008 433 440
25. E.P. Mensah-Brown, Z. Al Rabesi, A. Shahin, M. Al Shamsi, N. Arsenijevic, and D.K. Hsu Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice Clin Immunol 130 2009 83 88
26. H. Sano, D.K. Hsu, J.R. Apgar, L. Yu, B.B. Sharma, and I. Kuwabara Critical role of galectin-3 in phagocytosis by macrophages J Clin Invest 112 2003 389 397
27. Y.H. Liu, M. D'Ambrosio, T.D. Liao, H. Peng, N.E. Rhaleb, and U. Sharma N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiacremodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin Am J Physiol Heart Circ Physiol 296 2009 H404 H412
28. H.R. Jiang, Z. Al Rasebi, E. Mensah-Brown, A. Shahin, D. Xu, and C.S. Goodyear Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis J Immunol 182 2009 1167 1173
29. H. Forsman, U. Islander, E. Andréasson, A. Andersson, K. Onnheim, and A. Karlström Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis Arthritis Rheum 63 2011 445 454
30. Y.J. Lee, S.W. Kang, J.K. Song, J.J. Park, Y.D. Bae, and E.Y. Lee Serum galectin-3 and galectin-3 binding protein levels in Behçet's disease and their association with disease activity Clin Exp Rheumatol 25 2007 S41 S45
31. Y. Liu Renal fibrosis: new insights into the pathogenesis and therapeutics Kidney Int 69 2006 213 217
32. K. Miyazono TGF-beta signal by Smad proteins Cytokine Growth Factor Rev 11 2000 15 22
33. K. Kanasaki, D. Koya, T. Sugimoto, M. Isono, A. Kashiwagi, and M. Haneda N-Acetyl-seryl-aspartyl-lysyl-proline inhibits TGF-beta-mediated plasminogen activator inhibitor-1 expression via inhibition of Smad pathway in human mesangial cells J Am Soc Nephrol 14 2003 863 872